Discovery of IAP-Recruiting BCL-X(L) PROTACs as Potent Degraders across Multiple Cancer Cell Lines

Targeting BCL-X(L) via PROTACs is a promising strategy in reducing BCL-X(L) inhibition associated platelet toxicity. Recently, we reported potent BCL-X(L) PROTAC degraders that recruit VHL or CRBN E3 ligase. However, low protein expression or mutation of the responsible E3 ligase has been known to r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Med Chem
Main Authors: Zhang, Xuan, He, Yonghan, Zhang, Peiyi, Budamagunta, Vivekananda, Lv, Dongwen, Thummuri, Dinesh, Yang, Yang, Pei, Jing, Yuan, Yaxia, Zhou, Daohong, Zheng, Guangrong
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7325632/
https://ncbi.nlm.nih.gov/pubmed/32388279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejmech.2020.112397
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados